Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bulimia

• A Study of the Effects of Oxytocin in Adults With Obesity and Binge-eating Disorder
• Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder
• Naltrexone Neuroimaging Randomized Controlled Trial
• Pilot Study on BP1.4979 Effect on Binge Eating Disorders
• A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
• Oral Naltrexone In Pediatric Eating Disorders
• Naltrexone Neuroimaging
• Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
• Solriamfetol in Binge Eating Disorder
• A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
• Binge Eating & Birth Control
• Neurobiology of Bulimia Nervosa
• Effects of LDX on Cognitive Processes and Appetite
• Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment
• Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
• Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
• Lisdexamfetamine for Adults With Bulimia Nervosa
• Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia
• Binge Eating Liraglutide Intervention
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
• Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
• Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
• Dasotraline Binge Eating Disorder Extension Study
• Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects
• Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
• Dasotraline Binge Eating Disorder Study
• FDA Approved Medication to Reduce Binge Eating and/or Purging
• Vortioxetine for Binge Eating Disorder
• Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD
• Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
• Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
• Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls
• Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• A Double Blind Clinical Trial of DCS for Food Anxiety
• Neurobiology of Eating Disorders Treatments
• A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder
• Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
• Open Label Extension in Adults With Binge Eating Disorder (BED)
• Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray
• Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
• Pramipexole for Binge Eating Disorder
• ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
• Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
• An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
• N-acetylcysteine in the Treatment of Bulimia Nervosa
• Armodafinil in Binge Eating Disorder (BED)
• Topiramate Augmentation in Bulimia Nervosa Partial Responders
• Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
• Topiramate for Binge Eating Disorder Among Adolescents
• Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa
• Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
• Effect of a CCK-1R Agonist on Food Intake in Humans
• Treatment of Binge Eating in Obese Patients in Primary Care
• Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
• Sodium Oxybate in the Treatment of Binge Eating Disorder
• Acamprosate in the Treatment of Binge-Eating Disorder
• Craving, Binge Eating and Obesity
• A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
• An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
• Atomoxetine in the Treatment of Binge Eating Disorder
• Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
• An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.
• Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
• Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals
• Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
• Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity
• Treatment of Bulimia Nervosa in a Primary Care Setting